Did you know that 12% of women experience chronic or episodic migraines, and for many, they’re tied to hormonal cycles? In this episode of Hope in the Pipeline, Dr. Paul Wylie dives into the causes, symptoms, and treatments of menstrual migraines.

🧠In this episode, you’ll learn:

What causes menstrual migraines (hint: estrogen & hormone changes)

How they differ from common migraines

Why they often respond poorly to current medications What symptoms to look for, and how to track them

Why clinical trials matter—and how YOU can get involved

💊 About the Clinical Trial:

Open to individuals 18 years and older 18-week study, with the option for a 1-year extension

Medication is taken just 7 days a month to help prevent migraines

Compensation provided, plus free medication during the extension period if it helps

🧪 This trial is testing a promising FDA-approved treatment for menstrual migraines

In this episode of Hope in the Pipeline, Dr. Paul Wylie dives deep into chronic insomnia disorder—what causes it, how it affects both children and adults, and the latest research aimed at treating it.

🧠 Learn about: The types of insomnia symptoms Differences in diagnosing pediatric vs. adult insomnia Behavioral vs. pharmacological treatments The real-life impact of chronic sleep disruption Two new clinical trials are now enrolling participants (ages 10–17 and 18–65) Why your participation could help shape the future of insomnia treatment

📚 Plus: We're giving away 3 copies of Dr. Richard Ferber’s Solving Your Child’s Sleep Problems!

#Insomnia #SleepMedicine #ChronicInsomnia #clinicaltrials #clinicalstudy #sleepresearch

Attention Deficit Hyperactivity Disorder (ADHD) affects millions of children — but early diagnosis and the right treatment can make a world of difference. In this episode of Hope in the Pipeline, Dr. Paul Wylie, Neuropsychiatry and Sleep Medicine Specialist, explores the symptoms, causes, and treatment options for pediatric ADHD.

We also dive into an exciting new clinical research trial for children ages 4 to 5 years and 7 months, testing a non-controlled medication already approved for older children and adults. This trial could help shape the future of ADHD treatment — and eligible families may receive a formal diagnosis and compensation for participation.

Learn how ADHD presents differently in boys and girls, the role of genetics and sleep, and why your child’s struggles might have a biological solution.

📍 Visit PreferredResearchPartners.com to learn more or apply for the study.

🔔 Don’t forget to like, share, and subscribe for more episodes on mental health breakthroughs.